# Treatment of Cerebral Toxoplasmosis in HIV/AIDS

> **NCT00367081** · PHASE4 · COMPLETED · sponsor: **Department of Medical Services Ministry of Public Health of Thailand** · enrollment: 30 (—)

## Conditions studied

- Toxoplasmic Encephalitis
- AIDS

## Interventions

- **DRUG:** TMX-SMX (Bactrim(R))
- **DRUG:** Pyrimethamine plus Sulfadiazine plus leucoverin

## Key facts

- **NCT ID:** NCT00367081
- **Lead sponsor:** Department of Medical Services Ministry of Public Health of Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 30 (—)
- **Last updated:** 2007-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367081, "Treatment of Cerebral Toxoplasmosis in HIV/AIDS". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT00367081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*